See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2020_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,580,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,235,000 |
| 3 | remainder_Assets | 9,465,000 |
| 4 | LiabilitiesCurrent | 18,488,000 |
| 5 | LiabilitiesNoncurrent | 9,862,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 862,672 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,998,031 |
| 9 | ResearchAndDevelopmentExpense | 18,692,447 |
| 10 | remainder_Expenses | 764,597 |
| 11 | remainder_Revenues | 11,598,424 |
| 12 | remainder_NetIncome | 1,018,673 |
| 13 | remainder_ComprehensiveNetIncome | -2,288,629 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,280,000 |
| 1 | Liabilities | 28,350,000 |
| 2 | Expenses | 38,317,747 |
| 3 | Revenues | 11,598,424 |
| 4 | StockholdersEquity | 17,930,000 |
| 5 | NetIncome | -25,700,650 |
| 6 | ComprehensiveNetIncome | -26,844,964 |
| 7 | BaseVar | 63,926,736 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.328 |
| 9 | EconomicCapitalRatio | 1.73 |
Edgar->Model Mapping
Feature Distribution
Change over Time
